Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Amen. Nothing has changed.
Lol. Awesome. I'm debating which other positions to sell to buy more here. This is just stupid low and going to make me a ton of money. Buy the fear and show patience.
See ya. Soon
Balls of steel. Going to go play golf. I hope and pray all longs here that are true investors. Hold tight for the future. My crew grabbed 65 more K today. Locked
This shakeout means zero. If u don't sell it means nothing. The company is stronger than ever.
Delayed by how long man. Tell me.
Just sit back relax. I know it's hard but turn off CTIX for awhile. Come back in June for the CC. This is going no where. They don't need Aspire for several months. Deal is done. Just waiting to verify terms and amount based on data. This shake out will not cause harm on company. Just in shareholders who sell. I'm more than confident
Bahahaaa. Marked. I'd say we see $10-$15 by end of year if they decide to sell P. Mark this post. If Partnership maybe we see it depending on how short the crew is. A squeeze in bio is fun to watch
Here is a summary. CTIX said they were having a conference call and would give further details this week and would present an update specifically on trial data for B-Om and B-Up. We learned about a future conference call and where to submit questions. This CC today was pre-recorded and also updated us on current trial updates. I.e. - p interim data is now 3q not 1st half. Also there is studies on Bs effect on IL-17 which can lead to several more indications. We also learned more about current deals in the Gastro market.
I know exactly what people are trying to do here but all CTIX is doing is crushing trial after trial with great data and doing it in a financially respectable manner. 30 million shares converted to successfully put 8 human clinical trials in motion. I mean com'on people.
And they are mad?!?!? Why? Oh cuz there is a massive naked short beyond what any of us can fathom.
Com'on. CTIX will get the data for UP and P by mid summer and they will move to phase 3. Dilution is part of it. You have to pay to play.
I understand disappointment that it was just a rehash plus a little more insight on future projects...but there is nothing to be upset about other than pushing interim data 1 quarter further.
Im going to make sure mgmt understand the game that some of us know. This is excellent. We need to rehash this and do it like others said with a deal announced the next day on a Friday. It would squeeze the heck out of many. Put so many additional flippers out of position and make people cry. Great lesson learned Leo - do this again when the ink drys.
You are the best KarinCA! Thanks. So I agree this is just good for new investors and also for interested parties and just simple PR to get new investors excited about the Anti-Inflammatory properties of B. It is a possible branch of B that could be extremely lucrative and in the short term especially if B-OM keeps up the numbers. As Leo said they will go for FAST TRACK if the numbers keep pace.
I have listened to the presentation acouple times today and just looked over the slides for the first time just now. Here are a couple things that I did not know:
Additional research is underway to determine B's role in regulating IL-17>
B-OM - onset for B with greater than 3WHO - 45 days for the 2 patients
onset for 7 patients using placebo was 29 days.... so even for the 2 patients taking B it appears that it is still beneficial as it gives the patient 16 more days to eat or have less pain :)
How did they decide on 45 mg of B for OM? Why not a second arm with a different dose to help optimize the next phase 3? Just curious
Increased potential for Atopic Dermatitis, Hidradentis suppurativa, Acne
So what does that mean? There is manipulation?
I'm in a hurry to buy more shares to take away from sellers. Every week and month we accumulate and yes it has gone down but you and many others that sold or traded will not get them back. That's how we look at it.
I had another friend pick up 10K today. That is not earth shattering but 10K here and 10K there to a group that does not trade nor sell is good for CTIX and it's shareholders.
A couple 100K total that are locked.
I had the same thought. He would have played them like a fiddle. And so many would lose out
Pretty good results too. 2 of 9 got severe OM that took B. 7 of 10 got it in placebo. Small sample but very good indeed without any other drug in the prevention arena for soc
It's not the final results. But yes it was a result. It's the interim results of the 9 total patients that were treated with B. There will be more as the trial concludes.
Yes and the company has publicly stated they are further along in meetings than ever before with interested parties. Plus announcing several CDAs are in tact.
We are moving in good direction
Facts are good.
Just look at the posters today. Nough said right there. The same group. Great update today and great insight into potential market size...current deals and current efficacy for current drugs. We hopefully will trump them and become a market leader in all 3
Again. Great info with a bit more detail. Also advises additional areas that B can now move into. $$$$. This adds value to the pipeline.
Keep posting facts. Hound. Thx
Hopefully we get a little more detail today on the anti inflammatory properties of B
It's a great day when we get more PR on our drugs. Only 1 hour from presentation
Will it be B or P first? I bet it will be P after phase 2b results. My bet. No guys no glory Buns
Read and reread this; big money
Aspire Milestones:
Aspire was notified, on March 1, 2017, that it was awarded a significant 10-year government contract. Aspire is a strategic teammate on the CMS SPARC Indefinite Delivery/Indefinite Quantity (IDIQ) contracting vehicle. The ceiling on the IDIQ is $25B and is shared with multiple companies. The Prime requested Aspire join the team based on its healthcare past performance and powerful SDVOSB certification. Aspire successfully performed on a 2016 Cloud and Big Data healthcare project gaining critical past performance marks. The Aspire leadership team has substantial Health IT (HIT) experience and is connected to the HIT network in D.C.
The remaining teammates come from Fortune 500 companies and well-known Federal System Integrators. Strategic teaming is key to winning the numerous task orders delivered under this long-term IDIQ vehicle. The Aspire SPARC team is divided into specialty areas and set-aside certifications. The SPARC agreement offers substantial revenue opportunity for Aspire. Once task orders within the IDIQ are won, announcements and revenue guidance will be made. Task order revenues vary in size, but most are substantial and are multi-year arrangements split amongst the teammates.
There are strict SDVOSB work share mandates required by the U.S. government. The Veterans Benefit Act of 2003 requires each government agency to set aside at least 3% of contracts for SDVOSBs. On the state level, the percentages vary, but in most cases are higher. Aspire is competing for state contracts where the SDVOSB requirement is a minimum 7% of total revenue.
The SPARC agreement also provides Aspire the necessary past performance credentials to compete long-term and be successful with future contracting proposals. Past performance is a critical benchmark, in addition to procurement set-aside certifications. Aspire's SDVOSB certification is one of the most coveted in government contracting. The CMS SPARC contract is one of the largest IDIQs in government and carries substantial past performance metrics.
Aspire just submitted a proposal for the Veterans Affairs (VA) VECTOR SDVOSB contract. This is a $25B IDIQ centered on Management, Analysis, Training, Outreach, Supply Chain and Human Resource staffing. Aspire's team on VECTOR now awaits the award of this contract. Two other contracts are pending. One is for system modernization of a state's Motor Vehicle Administration (MVA) infrastructure. The other as a subcontractor on a key federal agency.
Aspire has teaming agreements with Northrop Grumman - the #2 federal systems integrator, Tech Mahindra - one of the largest business transformation firms in the world and a Direct hiring agreement with Phase One Consulting Group on its Department of Transportation (DOT) and Commodity Futures Trading Commission (CFTC) programs. The SDVOSB certification helps these companies hit specific government goals as it relates to veteran-owned business credits.
Aspire - Textmunication Partnership:
Textmunication acquired a minority-stake in Aspire gaining government contracting access. The partnership also allows Aspire's management team to open new SMS verticals in the government sector. Aspire is building-out a government contracting operation for the long-term.
The combination of government contracting access and new SMS opportunities makes the synergy strong. Textmunication will update the investment community once additional Aspire awards and task orders are won.
Agree. This is severely undervalued. It was at .09 a year ago and the business has more than doubled since then.
Big volume day? Huge Bid of over half billion.
Agree: market potential here is huge. Share structure is under control. And product seems to be disruptive.
All that equals large returns for early investors.
News always trumps charts
Thanks.
Their CEO is the reason I invested. I heard he actually went out to Cali to ensure this takes off! Just a rumor.
I'm praying Aspire brings in a monster contract. Just waiting for details.
Let it be. It doesn't matter in the end. CTIX's pipeline is very lucrative. Just waiting on data to confirm just how lucrative. Let the FUD and manipulator take this to where they want.
They don't need it. Period. A suitor is chosen imo. We are simply waiting for data to put a price tag on our products. Everyone. Needs to chill out. Go follow another stock while this drops to whatever Bunny said. Let it. It's not a big deal in the end. The only big deal for some is they sell and miss out when the deal is announced.
The only curveball that could happen is that a competitor suitor may out bid suitor one.
Let the negative FUD continue. It will not matter one bit in the end. Valuation goes by products and current markets. Every CTIX drug is in a very lucrative market and the designations and MOA's and development aspects are gold to each product. We are sitting on a golden nugget.
4 in a row. Lol.
TD. ASK 7k at .88. BID 3K at .881. Lol
Let them have fun for a couple more weeks/months. CTIX has this. No worries unless your short or not in a good position.
How is CDEL bidding at .881 and on the ASK at .88!?
What does the 505 b 2 do for extending that 15 year patent? Could it add 3-7 years?
Wais and David have really started to focus on controlling these notes and hopefully will pay off more in near future. This stock dropped from .10 because of the cds and bs that you speak of. We should be back above .10 shortly.
FUD. All day everyday here! At SOME POINT in time there has to be a reversal and correction (if CTIX continues to post successful trials)
There has to be. We need some kind of third party verification or coverage. It cannot be held down like it is with a pipeline that has 3 potential blockbusters.
Kaboooooom!!!!!!
I think above .02 with aspire as a 49% partner. I think this stock got punched in the gut from terrible fund raising. Tarpon bay Port. If mgmt can get a hold of dilution and future notes I think we see 52 week highs again very soon.
The facts are that this business is experiencing growth. And this aspire government connection could be the game changer.
Some past OS numbers
Nov 13 2014 - 78 million
Feb 11 2016 - 111 million
June 16 2016 - 111 million
Aug 2 2016 - 142 million
As of Feb I think it was like 2.2 billion but 2 billion of that was given to CEO so he continues to control the company so we are in the 200 million area. He needs to figure out a way to grant preferred shares so that 2 billion doesn't scare new investors. IMO. A little DD obviously proves its not in the float but people are lazy.
10-k watch. Starting this am.
Friday's the markets are closed. Next week we will have a conference call to relearn what is real and what is not. I expect mgmt to really key on that. This has become something I have rarely seen before and I personally am looking for reassurance they are on track.
It's sad to think even I a very strong advocate of CTIX has felt doubt for several milliseconds over the past months after reading this board too often. Well done to many of you for casting that shadow. I pray CTIX wins for myself and patients.